| Autor: |
Bhatla, Teena, Hogan, Laura E., Teachey, David T., Bautista, Francisco, Moppett, John, Velasco Puyó, Pablo, Micalizzi, Concetta, Rossig, Claudia, Shukla, Neerav, Gilad, Gil, Locatelli, Franco, Baruchel, André, Zwaan, C. Michel, Bezler, Natalie S., Rubio-San-Simón, Alba, Taussig, David C., Raetz, Elizabeth A., Mao, Zhengwei J., Wood, Brent L., Alvarez Arias, Diana, Krevvata, Maria, Nnane, Ivo, Bandyopadhyay, Nibedita, Lopez Solano, Lorena, Dennis, Robyn M., Carson, Robin, Vora, Ajay |
| Zdroj: |
Blood; November 2024, Vol. 144 Issue: 21 p2237-2247, 11p |
| Abstrakt: |
•Daratumumab plus chemotherapy may effectively bridge children and young adults with relapsed/refractory T-cell ALL/LL to HSCT.•No new safety concerns were identified with daratumumab treatment in children and young adults with B-cell ALL or T-cell ALL/LL. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
